(Q28259839)
Statements
A phase I study with adecatumumab, a human antibody directed against epithelial cell adhesion molecule, in hormone refractory prostate cancer patients (English)
0 references
October 2006
0 references
42
0 references
15
0 references
2530-8
0 references